Shizuoka, Japan

Miho Kurosawa

This inventor holds 1 USPTO granted patent. Top assignees: Daiichi Pharmaceutical Co., Ltd., Nof Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miho Kurosawa. Retrieved from https://idiyas.com/inventor/miho-kurosawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miho Kurosawa: Innovator in Phospholipid Derivatives

Introduction

Miho Kurosawa is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of phospholipid derivatives. Her innovative work has led to advancements in the modification of liposomes, which are crucial in various pharmaceutical applications.

Latest Patents

Miho Kurosawa holds a patent for a phospholipid derivative that is utilized for the modification of liposomes. This copolymer includes essential component units that enhance its functionality. The patent details a specific molar ratio of component units, ensuring optimal performance in applications involving liposomes.

Career Highlights

Throughout her career, Miho has worked with notable companies such as Nof Corporation and Daiichi Pharmaceutical Co., Ltd. Her experience in these organizations has allowed her to refine her expertise in biochemistry and contribute to groundbreaking research.

Collaborations

Miho has collaborated with esteemed colleagues, including Syunsuke Ohhashi and Kazuhiro Kubo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Miho Kurosawa's contributions to the field of phospholipid derivatives exemplify her dedication to innovation in biochemistry. Her work continues to influence the development of new pharmaceutical technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…